RBOT vs. LAKE, INGN, AVR, ZJYL, NTRB, MLSS, APT, SPAI, COCH, and CLGN
Should you be buying Vicarious Surgical stock or one of its competitors? The main competitors of Vicarious Surgical include Lakeland Industries (LAKE), Inogen (INGN), Anteris Technologies Global (AVR), Jin Medical International (ZJYL), Nutriband (NTRB), Milestone Scientific (MLSS), Alpha Pro Tech (APT), Safe Pro Group Inc. Common Stock (SPAI), Envoy Medical (COCH), and CollPlant Biotechnologies (CLGN). These companies are all part of the "surgical appliances & supplies" industry.
Vicarious Surgical vs. Its Competitors
Lakeland Industries (NASDAQ:LAKE) and Vicarious Surgical (NYSE:RBOT) are both small-cap industrials companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.
Lakeland Industries has higher revenue and earnings than Vicarious Surgical. Lakeland Industries is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.
Lakeland Industries presently has a consensus target price of $26.00, suggesting a potential upside of 86.78%. Vicarious Surgical has a consensus target price of $9.25, suggesting a potential upside of 17.30%. Given Lakeland Industries' stronger consensus rating and higher possible upside, equities research analysts clearly believe Lakeland Industries is more favorable than Vicarious Surgical.
In the previous week, Lakeland Industries had 29 more articles in the media than Vicarious Surgical. MarketBeat recorded 30 mentions for Lakeland Industries and 1 mentions for Vicarious Surgical. Lakeland Industries' average media sentiment score of 0.17 beat Vicarious Surgical's score of 0.00 indicating that Lakeland Industries is being referred to more favorably in the media.
Lakeland Industries has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500. Comparatively, Vicarious Surgical has a beta of 1.41, suggesting that its share price is 41% more volatile than the S&P 500.
Lakeland Industries received 199 more outperform votes than Vicarious Surgical when rated by MarketBeat users. Likewise, 61.98% of users gave Lakeland Industries an outperform vote while only 32.00% of users gave Vicarious Surgical an outperform vote.
71.7% of Lakeland Industries shares are held by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are held by institutional investors. 1.9% of Lakeland Industries shares are held by insiders. Comparatively, 12.0% of Vicarious Surgical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Vicarious Surgical has a net margin of 0.00% compared to Lakeland Industries' net margin of -0.42%. Lakeland Industries' return on equity of 1.66% beat Vicarious Surgical's return on equity.
Summary
Lakeland Industries beats Vicarious Surgical on 13 of the 17 factors compared between the two stocks.
Get Vicarious Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding RBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Vicarious Surgical Competitors List
Related Companies and Tools
This page (NYSE:RBOT) was last updated on 6/13/2025 by MarketBeat.com Staff